We will summarize and extend our discussion of the recently published study describing the use of Atrasentan, a selective Endothelin-A receptor blocker, in diabetic kidney disease. #NephJC.
Start Healing Your Kidneys Today!
Start Healing Your Kidneys Today!
Subscribe to:
Post Comments (Atom)
Start Healing Your Kidneys Today!
Start Healing Your Kidneys Today!
No comments:
Post a Comment